Effect of Hepatic Impairment on the Pharmacokinetics of Alectinib

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 4, 2015

Primary Completion Date

December 8, 2016

Study Completion Date

December 8, 2016

Conditions

Hepatic Impairment

Interventions

DRUG

Alectinib

Participants will receive alectinib as per the dosage schedule mentioned in arm description.

Trial Locations (2)

Pharmaceutical Research Associates CZ, s.r.o., Prague

Summit Clinical Research s.r.o.; Oddelenie internej mediciny a klinickej farmakologie, Bratislava

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT02621047 - Effect of Hepatic Impairment on the Pharmacokinetics of Alectinib | Biotech Hunter | Biotech Hunter